ALUR
Allurion Technologies Inc

2,204
Mkt Cap
$9.07M
Volume
39,862.00
52W High
$3.83
52W Low
$0.23
PE Ratio
-0.10
ALUR Fundamentals
Price
$0.739
Prev Close
$0.80
Open
$0.7805
50D MA
$1.13
Beta
1.04
Avg. Volume
8.12M
EPS (Annual)
-$3.20
P/B
-0.07
Rev/Employee
$234,379.56
$46.70
Loading...
Loading...
News
all
press releases
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE
Allurion Technologies, Inc. (the Company) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, has received notice from the New York Stock Exchange (NYSE) that it intends to initiate...
Business Wire·20d ago
News Placeholder
More News
News Placeholder
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?
Here is how Allurion Technologies, Inc. (ALUR) and McKesson (MCK) have performed compared to their sector so far this year.
Zacks·23d ago
News Placeholder
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
Allurion Technologies, Inc. (NYSE: ALUR) (the Company or Allurion), a pioneer in metabolically healthy weight loss, today announced the entry into a definitive agreement for the immediate exercise of...
Business Wire·26d ago
News Placeholder
Power Hour Surge: Cover Story, FDA Catalysts, Rare Earths, and a $7.8B Biotech Buyout
As the final hour of trading unfolds, momentum is clustering around breakthrough science, regulatory catalysts, strategic commodities, and headline M&A. Here are the stocks commanding attention into the close and potentially into afterhours.
24-7 Market News·26d ago
News Placeholder
Why Did Allurion Stock Surge Over 50% Today?
The U.S. Food and Drug Administration has granted premarket approval for Allurion’s Gastric Balloon System with the swallowable Allurion Smart Capsule.
Stocktwits·27d ago
News Placeholder
Allurion Receives U.S. FDA Approval
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval (PMA...
Business Wire·27d ago
News Placeholder
Allurion Announces Partnership to Offer Combination Therapy with Mounjaro (tirzepatide) at Discounted Prices
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a partnership with Bionut, a leader in obesity care in Argentina, and Farmastar, a local...
Business Wire·2mo ago
News Placeholder
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced preliminary, unaudited results for the fourth quarter and full year 2025. Management expects...
Business Wire·2mo ago
News Placeholder
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the publication of a peer-reviewed, case-controlled study on the use of the Allurion Smart...
Business Wire·4mo ago
News Placeholder
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a strategic distribution partnership with ProSurg Medical, a leading Brazilian medical device...
Business Wire·4mo ago
<
1
2
...
>

Latest ALUR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.